Close

KAT6A

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes a member of the MOZ, YBFR2, SAS2, TIP60 family of histone acetyltransferases. The protein is composed of a nuclear localization domain, a double C2H2 zinc finger domain that binds to acetylated histone tails, a histone acetyl transferase domain, a glutamate/aspartate rich region, and a serine and methionine rich transactivation domain. It is part of a complex that acetylates lysine 9 residues in histone 3, and in addition, it acts as a co activator for several transcription factors. Allelic variants of this gene are associated with an autosomal dominant form of cognitive disability. Chromosomal translocations of this gene are associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants.
  • TCR Vector Products

  • TCR Cell Products

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-ZP511 Human anti-KAT6A T cell receptor (JB11), pCDTCR1 HCV JB11 Human KLSREIMPV HLA-DRB5 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP512 Human anti-KAT6A T cell receptor (KH10), pCDTCR1 HCV KH10 Human KLSREIMPV HLA-DRB5 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP513 Human anti-KAT6A T cell receptor (LC9), pCDTCR1 HCV LC9 Human KLSREIMPV HLA-DRB5 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP514 Human anti-KAT6A T cell receptor (LG6), pCDTCR1 HCV LG6 Human KLSREIMPV HLA-DRB5 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP515 Human anti-KAT6A T cell receptor (NC1), pCDTCR1 HCV NC1 Human KLSREIMPV HLA-DRB5 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.